patentgrepDocs Get an API key

A61K 47/6823

Double chain ricin

Official title: {Double chain ricin}

A61K47/6823 (Double chain ricin) appears on 27 US grants and 34 published applications in this corpus.

Search patents in A61K

Granted patents: 27
Published applications: 34
Assignees: 24
Inventors: 60
Latest grant: 24 Mar 2026

Filings by year

A61K 47/6823: granted patents and published applications per publication year
Year	Granted patents	Published applications
1982	1	0
1983	1	0
1984	0	0
1985	0	0
1986	0	0
1987	0	0
1988	0	0
1989	1	0
1990	0	0
1991	1	0
1992	0	0
1993	0	0
1994	0	0
1995	0	0
1996	0	0
1997	0	0
1998	0	0
1999	1	0
2000	0	0
2001	1	0
2002	0	1
2003	0	0
2004	0	0
2005	0	1
2006	1	2
2007	0	0
2008	1	1
2009	0	2
2010	2	3
2011	1	1
2012	2	2
2013	1	1
2014	1	0
2015	1	4
2016	1	1
2017	2	1
2018	1	2
2019	1	2
2020	1	1
2021	0	2
2022	1	3
2023	2	1
2024	1	2
2025	0	0
2026	1	1

By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.

Recent patents

Therapeutic constructs for co-delivery of anti-cancer agent(s) and immune checkpoint inhibitor(s)24 Mar 2026US 12,582,658 B2Oregon Health & Science University
Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor13 Aug 2024US 12,059,500 B2Oregon Health & Science University
Monoclonal antibodies against Claudin-18 for treatment of cancer29 Aug 2023US 11,739,139 B2Astellas Pharma Inc.
Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor20 Jun 2023US 11,679,082 B2Oregon Health & Science University
Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor18 Jan 2022US 11,224,573 B2Oregon Health & Science University

Most cited

By later US patents